IP Cases — 2015
129 decisions across all jurisdictions
Page 5 of 5 · 129 total
Babu Ram Om Prakash v.Pradhan Herbal Company
This case involved a dispute between Babu Ram Om Prakash and Pradhan Herbal Company concerning the use of the trademark 'Diamond/Black Diamond' in relation to Henna Power (Mehandi). Following mandatory mediation, the parties reached a comprehensive Settlement Agreement. The court accepted this agreement, decreeing the suit based on its terms, which prohibited the defendant from using the plaintiff's mark or similar labels.
Symed Labs Ltd. v.Glenmark Pharmaceuticals Ltd.
Symed Labs Ltd. filed a suit alleging that Glenmark Pharmaceuticals Ltd. was manufacturing and selling Linezolid using processes that infringed upon Symed's registered patents (IN '062 and IN '063). The Plaintiff argued that its patented methods were more economical, safer, and commercially viable than the prior art processes. The court granted an ad interim injunction restraining the Defendants from continuing the infringing activities.
Sun Pharmadeuticals Industries Ltd. v.Stadmed Pvt. Ltd. & Anr.
The Calcutta High Court allowed an application for amendment of the cause title, recognizing that the rights in the trademark 'ZOLAM' had been transferred from Sun Pharmadeuticals Industries Ltd. to Sun Pharma Laboratories Limited via a sanctioned scheme of arrangement. The court found the plaintiff's case unimpeachable and ruled that the successor company was entitled to continue the legal proceedings without delay.
Maharashtra Hybrid Seed Co. v.Union Of India And Anr
The petitioners challenged an order by the Registrar of PPVFR Authority which held that parent lines of known hybrid varieties could not be registered as 'new' plant varieties. The core issue was whether these parent lines retained novelty despite the commercial use and sale of resulting hybrid seeds.
Maharashtra Hybrid Seed Co. v.Union Of India And Anr
The petitioners challenged an order by the Registrar, PPV&FR Authority, which held that parent lines of known hybrid varieties could not be registered as 'new' plant varieties. The core issue was whether the development and sale of hybrid seeds from these parent lines invalidated the novelty claim for the original parental lines.
Maharashtra Hybrid Seed Co. v.Union Of India
The petitioners challenged an order by the Registrar, PPVFR Authority, which held that parent lines of known hybrid varieties could not be registered as new plant varieties. The core issue was whether the parent lines remain novel if their material is used to produce a distinct hybrid variety.
Novartis Ag v.Cipla Ltd
Novartis AG filed a suit against Cipla Ltd alleging infringement of its patented drug, INDACATEROL Maleate, used for treating COPD. Novartis sought a permanent injunction to restrain the use and sale of the infringing product. The Delhi High Court addressed the interim application, noting that while the defendant had not applied for compulsory licensing, the grounds under the Patents Act were relevant. Consequently, the court granted an interim injunction restraining Cipla from manufacturing or selling INDACATEROL Maleate until the final outcome of the suit.
Maharashtra Hybrid Seed Co. v.Union Of India And Anr
The petitioners challenged an order by the Registrar, PVPFR Authority, which held that parent lines of known hybrid varieties could not be registered as new plant varieties. The core issue was whether the parent lines remain novel if their material is used to produce a distinct hybrid variety.
Maharashtra Hybrid Seed Co. v.Union Of India And Anr
The petitioners challenged an order by the Registrar, PPVFR Authority, which held that parent lines of known hybrid varieties could not be registered as 'new' plant varieties. The core issue was whether these parent lines retained novelty despite the commercial use and sale of resulting hybrid seeds.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.